CommercialCoverageHigh impact
Intranasal Ablation (CPB 0592, reviewed 2025-09-10)
Aetna·ENT (Ear, Nose & Throat)·Surgery
Effective date
Sep 10, 2025
We identified it
Aug 16, 2026
Summary
Aetna's updated Clinical Policy Bulletin 0592 clarifies coverage for intranasal radiofrequency ablation (RFVTR/Somnoplasty). Coverage is LIMITED to CPT 30801-30802 for chronic nasal obstruction due to inferior turbinate mucosal hypertrophy only. RFVTR for snoring, sleep apnea, allergic rhinitis, and multiple alternative ablation methods are NOT covered. Billing teams must ensure strict diagnosis code alignment and deny claims for non-covered indications.
Action Required
IMMEDIATE (effective 2025-09-10): Billing team must update claims processing system with the following rules: (1) CPT 30801 and 30802 are COVERED ONLY when billed with ICD-10 J34.0, J34.1, J34.3, or J34.81-J34.9 (chronic nasal obstruction/turbinate hypertrophy). (2) CPT 30801 and 30802 are NOT COVERED when billed with G47.33 (sleep apnea), J30.1-J30.9 (allergic rhinitis), J31.0 (chronic rhinitis/rhinitis medicamentosa), or R06.83 (snoring) — DENY these claims with reason code 'Non-covered indication.' (3) CPT 31242, 31243, and 30117 are NEVER COVERED — auto-deny with 'Non-covered procedure.' (4) Add hard-stop edits in billing software to flag any 30801/30802 claim paired with non-covered diagnoses BEFORE submission to prevent denials. (5) Update encounter templates and provider documentation guidance to clarify that only turbinate hypertrophy (not sleep apnea, allergic rhinitis, or snoring) qualifies for coverage. (6) Providers and front desk staff must verify diagnosis at scheduling and before service delivery. Failure to apply these edits will result in claim denials and revenue loss.